CompareEko HealthvsSully.ai

Eko Health combines digital stethoscopes with AI to detect heart and lung conditions during exams.

1. Clinical role: It supports cardiac assessment and risk stratification rather than autonomous cardiology, so clinician review remains essential for treatment and reporting decisions.
2. Best-fit environment: Primary care and cardiology clinicians fit best when AI stethoscope signals align with examination and referral pathways.
3. Implementation checks: Buyers should confirm regulatory clearance scope, imaging modality fit, reporting integration, validation evidence, and clinician review requirements before rollout.
4. Commercial model: Pricing is sales-led and scoped per buyer rather than publicly posted, making implementation scope a purchasing consideration.

Eko Health is best assessed as a focused cardiology support layer whose value depends on clinical oversight, workflow fit, and confirmation of positive findings.

Sully.ai is an AI medical scribe and clinical assistant for clinics and physician practices, supporting ambient capture, structured note drafting, and documentation workflows.

1. Clinical role: It supports documentation rather than autonomous clinical decision-making, so clinician review of every drafted note remains essential before sign-off.
2. Best-fit environment: Clinics and physician practices may benefit most when specialty requirements and EHR workflows align with the product’s documentation approach.
3. Implementation checks: Buyers should assess specialty fit, EHR integration depth, documentation accuracy, clinician training, and rollout requirements before deployment.
4. Commercial model: Pricing is sales-led and scoped per buyer rather than publicly posted, making implementation scope an important purchasing consideration.

Sully.ai is best evaluated through a focused workflow pilot that tests documentation fit, clinician review, and readiness before scaling across teams.